CST1 and allergic rhinitis: The protein encoded by the key driver of the PM2.5 network in children without asthma, CST1, is known to have protective roles, including the inhibition of allergen protease activity, [81] reduction of airway tight junction disruption [82], and association with successful symptom control and decreased Type 2 cells in a clinical trial of immunotherapy for allergic rhinitis.